Ischaemic brain damage after stroke: New insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection

EMBO Reports

Volumn 8, Issue 2, 2007, Pages 129-133

  Culmsee, Carsten ^a   Krieglstein, Josef ^b,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID SENSING ION CHANNEL; ALBUMIN; ANTIOXIDANT; APOPTOSIS INDUCING FACTOR; ATORVASTATIN; BIM PROTEIN; CALCIUM; CALCIUM CHANNEL; CASPASE; CYTOCHROME C; DISUFENTON SODIUM; DNA FRAGMENT; ERYTHROPOIETIN; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; MINOCYCLINE; NUCLEOLIN; NUCLEOPHOSMIN; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SILDENAFIL; SMALL INTERFERING RNA; TISSUE PLASMINOGEN ACTIVATOR;

APOPTOSIS; BLEEDING; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL PH; CLINICAL TRIAL; CONFERENCE PAPER; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DOSE ESCALATION; DRUG MEGADOSE; HUMAN; HUMAN GENOME; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; STROKE; SYMPOSIUM;

APOPTOSIS; BRAIN ISCHEMIA; CALCIUM; CEREBROVASCULAR ACCIDENT; HUMANS; MODELS, BIOLOGICAL; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 33947288475     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400892     Document Type: Conference Paper

References (18)

1. Becattini B, Culmsee C, Leone M, Zhai D, Zhang X, Crowell KJ, Rega MF, Landshamer S, Reed JC, Plesnila N, Pellecchia M (2006) Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting Bid. Proc Natl Acad Sci USA 103: 12602-12606
2. Chamorro A, Horcajada JP, Obach V, Vargas M, Revilla M, Torres F, Cervera A, Planas AM, Mensa J (2005) The Early Systemic Prophylaxis of Infection After Stroke study: A randomized clinical trial. Stroke 36: 1495-1500
3. Chao DT, Korsmeyer SJ (1998) BCL-2 family: Regulators of cell death. Annu Rev Immunol 16: 395-419
4. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331: 761-777
5. Culmsee C, Zhu C, Landshamer S, Becattini B, Wagner E, Pellecchia M, Blomgren K, Plesnila N (2005) Apoptosis-inducing factor triggered by poly(ADP-ribose) polymerase and Bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 25: 10262-10272
6. del Zoppo GJ, Mabuchi T (2003) Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab 23: 879-894
7. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D (2006) The ALIAS Pilot Trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke. I: Physiological responses and safety results. Stroke 37: 2100-2106
8. Iadecola C, Alexander M (2001) Cerebral ischemia and inflammation. Curr Opin Neurol 14: 89-94
9. Klumpp S, Krieglstein J (2002a) Phosphorylation and dephosphorylation of histidine residues in proteins. Eur J Biochem 269: 1067-1071
10. Klumpp S, Krieglstein J (2002b) Serine/threonine protein phosphatases in neuronal apoptosis. Curr Opin Pharmacol 2: 458-462
11. Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hardemark HG, Wasiewski WW: Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators (2006) NXY-059 for acute ischemic stroke. N Engl J Med 354: 588-600
12. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U (2005) Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 6: 775-786
13. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4: 552-565
14. Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD (2006) The ALIAS Pilot Trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke. II: Neurologic outcome and efficacy analysis. Stroke 37: 2107-2114
15. Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A (2006) Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37: 2607-2612
16. Tonks NK (2005) Redox redux: Revisiting PTPs and the control of cell signaling. Cell 121: 667-670
17. Vargas M, Horcajada JP, Obach V, Revilla M, Cervera A, Torres F, Planas AM, Mensa J, Chamorro A (2006) Clinical consequences of infection in patients with acute stroke: Is it prime time for further antibiotic trials? Stroke 37: 461-465
18. Zhang RL, Zhang ZG, Chopp M (2005) Neurogenesis in the adult ischemic brain: Generation, migration, survival, and restorative therapy. Neuroscientist 11: 408-416